PATLY.AIApplication
19625030 · RISK EVALUATION AND MANAGEMENT STRATEGY INVOLVING PATIENT FOLLOW-UPS RELATING TO THE USE OR DISCONTINUATION OF A COMPLEMENT INHIBITOR
Filed 2026-09-17 · Pending The official file ↗ · Art unit · Alexion Pharmaceuticals, Inc. · Alexion Pharmaceuticals
Office actions
0
first was
RCEs
0
no appeal
To first action
n/a
to disposition n/a
Statutes raised
·
0 actions read